Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Arylacetamide deacetylase | ||
Ligand | BDBM50454599 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_1752877 (CHEMBL4187637) | ||
IC50 | 5400±n/a nM | ||
Citation | Kodani, SD; Bhakta, S; Hwang, SH; Pakhomova, S; Newcomer, ME; Morisseau, C; Hammock, BD Identification and optimization of soluble epoxide hydrolase inhibitors with dual potency towards fatty acid amide hydrolase. Bioorg Med Chem Lett28:762-768 (2018) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Arylacetamide deacetylase | |||
Name: | Arylacetamide deacetylase | ||
Synonyms: | AAAD_HUMAN | AADAC | Arylacetamide deacetylase | DAC | ||
Type: | PROTEIN | ||
Mol. Mass.: | 45743.18 | ||
Organism: | Homo sapiens (Human) | ||
Description: | ChEMBL_109673 | ||
Residue: | 399 | ||
Sequence: |
| ||
BDBM50454599 | |||
n/a | |||
Name | BDBM50454599 | ||
Synonyms: | CHEMBL4216368 | ||
Type | Small organic molecule | ||
Emp. Form. | C20H21F3N2O4 | ||
Mol. Mass. | 410.3869 | ||
SMILES | Oc1ccc(O[C@H]2CC[C@@H](CC2)NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1 |r,wU:6.5,wD:9.12,(74.54,-31.49,;73.21,-30.71,;71.87,-31.48,;70.54,-30.71,;70.55,-29.17,;69.22,-28.4,;67.88,-29.16,;67.88,-30.7,;66.55,-31.47,;65.22,-30.69,;65.21,-29.16,;66.55,-28.39,;63.89,-31.47,;62.55,-30.7,;62.55,-29.16,;61.22,-31.47,;59.89,-30.7,;58.55,-31.47,;57.22,-30.7,;57.22,-29.16,;55.88,-28.39,;55.88,-26.85,;55.88,-25.45,;57.13,-25.83,;54.63,-25.83,;58.55,-28.39,;59.88,-29.15,;71.88,-28.4,;73.21,-29.17,)| | ||
Structure |